Curis, Inc. (CRIS) Stock: Seeing Gains In Today’s Session


Curis, Inc. (CRIS) is headed up in the market in today’s trading session. The stock, one that is focused on the biotechnology industry, is presently priced at $2.04 after a move up of 9.68% so far today. In terms of biotechnology companies, there are a number of aspects that have the ability to cause price movement in the market. One of the most common is news. Here are the most recent headlines surrounding CRIS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-05-19 04:01PM Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jun-12-19 07:00AM Curis Highlights Publication in Nature Cell Biology Identifying Cancer-Causing Form of IRAK4 in Patients with AML and MDS
May-21-19 11:20AM Edited Transcript of CRIS earnings conference call or presentation 14-May-19 8:30pm GMT
May-14-19 04:29PM Curis: 1Q Earnings Snapshot
04:05PM Curis Reports First Quarter 2019 Financial Results

However, any time investors are making a decision with regard to investing, investors should focus on much more than just news, especially in the speculative biotechnology industry. Here’s what’s happing when it comes to Curis, Inc..

Performance Trends That We’ve Seen From CRIS

Although a single session gain, like the gain that we’re seeing from Curis, Inc. might cause excitement in some investors, that by itself should not be the reason for a decision to, or not to, invest in a company. It is always a good idea to look at trends experienced by the stock just a single trading day. As it relates to CRIS, here are the returns on investment that investors have seen:

  • Past 7 Days – Over the last 7 days, CRIS has produced a price change in the amount of 13.97%.
  • Monthly – The ROI from Curis, Inc. in the past 30 days has been 40.69%.
  • Past 3 Months – Throughout the past quarter, the company has generated a return of -8.11%
  • Bi-Annually – In the previous six months, investors have seen a performance that works out to 117.02% from the stock.
  • Year To Date – Since the the first trading session of this year CRIS has produced a return on investment of 195.74%.
  • Full Year – Lastly, in the last year, we’ve seen performance in the amount of 10.27% from CRIS. Throughout this period of time, the stock has sold at a high of -23.02% and a low of 240.00%.

Ratios To Watch

Digging into various ratios associated with a stock generally gives prospective traders an understanding of just how dangerous and/or rewarding a an investment option might be. Below are a few of the most important ratios to think about when looking at CRIS.

Short Ratio – The short ratio is a tool that is used by investors to measure the amount of short interest. The higher this ratio, the more investors believe that the value of the stock is going to go down. In general, biotechnology stocks tend to carry a higher short ratio. However, we also see a lot of short squeezes in the sector. Nonetheless, in relation to Curis, Inc., it’s short ratio is 3.54.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Basically, they measure If a company is able to cover its debts as they mature based on quick assets or current assets. Because many biotech companies are heavily reliant on the continuation of support from investors, the quick and current ratios can be upsetting. However, some better companies in the biotech sector come with positive quick and current ratios. As it relates to CRIS, the quick and current ratios work out to 9.80 and 9.80 respectively.  

Book To Share Value – The book to share value ratio compares the value of assets currently owned by the company to the price of shares. In this case, the book to share value ratio equates to -0.41.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Several early stage biotechnology companies have a hard time keeping cash on hand. So, when investing in the biotech space, this is an important ratio to look into. When it comes to CRIS, the cash to share value works out to 1.31.

How Analysts Feel About Curis, Inc.

Although it’s not a smart idea to avoid doing your DD and blindly following the opinions of analysts, it is a good idea to use their thoughts in order to validate your own opinions before making an investment decision in the biotechnology sector. Here are the recent moves that we’ve seen from analysts as it relates to CRIS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Oct-24-17 Initiated Guggenheim Buy $7
Mar-02-16 Initiated Sun Trust Rbsn Humphrey Buy $3
Nov-09-15 Reiterated ROTH Capital Buy $6 → $5
Aug-11-15 Initiated FBR Capital Outperform $6
Jan-22-15 Reiterated Oppenheimer Outperform $3 → $5

Big Money And Curis, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in CRIS, here’s what we’re seeing:

  • Institutions – As it stands now, institutional investors own 24.10% of Curis, Inc.. However, it is worth considering that institutional ownership has changed in the amount of 0.60% over the past 3 months.
  • Investors On The Inside – When it comes to insiders, those close to the company currently hold 0.50% of Curis, Inc.. Insider ownership of the company has seen a move of -32.23% over the past quarter.

Interested In How Many Shares Are Available?

Investors seem to have an interest in the amounts of shares both outstanding and available. When it comes to Curis, Inc., there are currently 32.63M with a float of 27.47M. This means that out of the total of 32.63M shares of CRIS currently in existence today, 27.47M are able to be traded in the public realm.

It’s also important to take a look at the short float. After all, when a high percentage of the float is shorted, the overall feeling among investors is that the stock is going to fall hard. As far as CRIS, the short percentage of the float totals up to 1.73%. Most investors would say that a high short percent of the float is any percentage over 40%. Through my work, I’ve found that any short ratio over 26% is generally a play that comes with hefty risk.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $0. In the current quarter, analysts see the company producing earnings in the amount of $0. Over the last 5 years, CRIS has generated revenue in the amount of $-7.00% with earnings coming in at -5.60%. On a quarter over quarter basis, earnings have seen movement of 8.30% and revenue has seen movement of -28.00%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. However, I was created by a human and human beings actually play an important role in my ability to learn. Sure, I can look through social media trends and other publicly available data, but, like humans, I learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other information that captures your interest? Should I say something differently? Is there another way to look at data? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here